Stockscreener 앱 받기
143.52
2.82%
-4.17
시간 외 거래:
143.52
Insulet Corp 주식(PODD)의 최신 뉴스
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
Insulet Stock (US45784P1012): Ownership Changes Put Diabetes Tech Group in Focus - AD HOC NEWS
Insulet Corp. stock outperforms competitors on strong trading day - MSN
Top medtech stories from ADA’s Scientific Sessions - MedTech Dive
Why is Insulet (PODD) down 8.7% since last earnings report? - MSN
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Insulet Corp. stock underperforms Wednesday when compared to competitors - MSN
Is Insulet Corporation (PODD) A Good Stock To Buy Now? - Yahoo Finance
Truist cuts Insulet stock price target to $219 on valuation - Investing.com
Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System Updates - Yahoo Finance
Insulet Corporation $PODD Shares Sold by Allianz Asset Management GmbH - MarketBeat
Insulet Corp (PODD) Shares Surge 5.3% -- What GF Score of 82 Tel - GuruFocus
Insulet Independent Chair Acquires 66% More Stock - Moomoo
Insulet reports new data for Omnipod 6 and FCL systems - MSN
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option - Insider Monkey
Insulet (PODD) Reveals Promising Advances in Automated Insulin D - GuruFocus
Prudential PLC Has $5.68 Million Stock Position in Insulet Corporation $PODD - MarketBeat
CIBC Asset Management Inc Purchases 6,821 Shares of Insulet Corporation $PODD - MarketBeat
5 Oversold Stocks to Buy Right Now - Insider Monkey
ETFs Investing in Insulet Corporation Stocks - TradingView
Soleus Capital Management, L.P.'s Insulet Corp(PODD) Holding History - GuruFocus
INSULET CORP (NASDAQ:PODD) Fits the Affordable Growth Mold with Strong Momentum and Reasonable Valuation - ChartMill
Insulet presents clinical trial data for diabetes devices - Investing.com
Insulin pump trials: Omnipod 6 lifts time in range with fewer boluses - Stock Titan
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care - Yahoo Finance
Earnings call transcript: Insulet’s Q1 2026 earnings beat expectations, stock dips - Investing.com
Insulet shares surge 9% on strong earnings beat - Investing.com
Federal Circuit Overturns $59 Million Trade Secret Award Against EOFlow In Statute Of Limitations Ruling - londoninsider.co.uk
Insulet shares rise as investors focus on Omnipod 5 software upgrade and expanded CGM compatibility - Quiver Quantitative
Moody’s revises Insulet outlook on product recall concerns - Investing.com
PODD Stock Balances Device Setback With Omnipod Upgrade Momentum - StocksToTrade
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report? - Yahoo Finance
Divided Federal Circuit Panel Nixes $452 Million Trade Secret Judgment as Time-Barred - Holland & Knight
Dexcom buys Nutrisense; Insulet rolls out patch pump update - Yahoo Finance
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)? - Yahoo Finance
Insulet Q1 2026 slides: 34% revenue growth amid stock decline - Investing.com
Insider Buying: Timothy Stonesifer Acquires Shares of Insulet Co - GuruFocus
Insulet Corp director Luciana Borio sells $59,886 in stock - Investing.com UK
Insulet Corp director Luciana Borio sells $59,886 in stock By Investing.com - Investing.com Australia
Insulet Corp director Timothy Stonesifer acquires $400,392 in stock By Investing.com - Investing.com India
Insulet Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Insulet Corp director Timothy Stonesifer acquires $400,392 in stock - Investing.com
[Form 4] INSULET CORP Insider Trading Activity - Stock Titan
Insulet (NASDAQ: PODD) director sells 418 shares in open-market trade - Stock Titan
Insulet director Elizabeth Weatherman buys $497k in shares By Investing.com - Investing.com India
Insulet (PODD) Alerts Customers About Omnipod Pod Safety Concern - GuruFocus
Insulet (PODD) Outlines Plans for ADA 2026 Presentation - GuruFocus
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026? - The Motley Fool
3 Reasons We’re Fans of Insulet (PODD) - Yahoo Finance
Why is Insulet stock rallying today? - Investing.com
Why is Insulet stock rallying today? By Investing.com - Investing.com India
Federal Circuit applies unforgiving standard for accrual of statute of limitations on DTSA claims - White & Case LLP
How Insulet’s next-gen Omnipod is designed to reduce the work of diabetes care - Stock Titan
Insulet launches algorithm improvements for Omnipod 5 AID system in US - Yahoo
Insulet director Elizabeth Weatherman buys $497k in shares - Investing.com UK
2.43%
자본화:
|
볼륨(24시간):